Mackenzie Financial Corp Tandem Diabetes Care Inc Transaction History

Mackenzie Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$35.49 - $56.15 $285,588 - $451,839	8,047 New	8,047 $361,000
Q2 2022 Aug 10, 2022	SELL	$53.22 - $123.09 $117,084 - $270,798	-2,200 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$101.89 - $150.09 $224,158 - $330,198	2,200 New	2,200 $256,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.